Assorted News from the Last Week: Findings from a cohort study published in JAMA Network Open found that survivors of childhood cancer who lived in

Assorted News from the Last Week: Results from a new study show that giving a drug called dexrazoxane (Zinecard) before each dose of doxorubicin substantially

Assorted News from the Last Week: This year’s Grand Challenge includes a focus on pediatric solid tumors! One of the nine announced challenges seeks to

Assorted News from the Last Week: In March last year, the CCDI Molecular Characterization Initiative (MCI) launched. Since then, it has opened enrollment to children,

Assorted News from the Last Week: National Cancer Institute (NCI) is launching a first-of-its-kind, public-private partnership to bring clinical and patient navigation support to families

Assorted News from the Last Week: Investigators have found that socioeconomic deprivation, the presence of modifiable chronic health conditions, and frailty may all independently be

Assorted News from the Last Week: Microchip disruption due to the pandemic is trickling down to impact access to hearing aids. Pediatric cancer survivors appeared

Assorted News from the Last Week: National Cancer Institute (NCI) is launching the Childhood Cancer – Data Integration for Research, Education, Care, and Clinical Trials

Assorted News from the Last Week: Reporting by the Bureau of Investigative Journalism, in partnership with STAT, reveals that at least a dozen brands of

Assorted News from the Last Week: More about the Food and Drug Administration (FDA) approval of the drug brentuximab vedotin (Adcetris) in combination with chemotherapy